1. Product Overview
2. Research Methodology
3. Impact of COVID-19
on Oxcarbazepine Market
4. Executive Summary
5. Manufacturing
Oxcarbazepine
5.1.
Raw Material
5.2.
Machinery
5.3.
Manufacturing Methods
5.4.
Contact Details of Machinery & Raw Material Suppliers
6. Pharmacodynamic
Overview of Oxcarbazepine
6.1.
Mechanism of Action
6.2.
Absorption
6.3.
Volume of Distribution
6.4.
Protein Binding
6.5.
Metabolism
6.6.
Route of Elimination
6.7.
Half-Life
6.8.
Clearance
6.9.
Toxicity
7. India Oxcarbazepine
Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value &
Volume
7.2.
Market Share & Forecast
7.2.1. By Source (In-house
v/s Contract Manufacturing Organizations)
7.2.2. By Form (Tablet v/s
Oral Suspension)
7.2.3. By Distribution
Channel (Online v/s Offline)
7.2.4. By Application
(Epilepsy, Neuropathic Pain, Seizures and Others)
7.2.5. By End User (Adult
v/s Paediatric)
7.2.6. By Region (North,
East, South, West)
7.2.7. By Company
7.3.
Product Market Map
8.
Market Dynamics
8.1.
Drivers/Opportunities
8.2.
Challenges/Restraints
9.
Market Trends & Developments
10.
Policy & Regulatory Landscape
10.1.
Custom Duty & Taxes
10.2.
Government Subsidy & Benefits
10.3.
Relevant Policies & Regulations (GMP, USFDA, WHO
Certifications)
11.
Import & Export Analysis
12.
Pricing Analysis
13.
India Economic Profile
14.
Competitive Landscape
14.1.
Company Profiles
14.1.1. Sun Pharmaceuticals
Industries Ltd.
14.1.1.1. Company Brief
14.1.1.2. Production Plants
& Capacity (If Available)
14.1.1.3. Financials (If
Available)
14.1.1.4. Captive Consumption
Vs Merchant Sale
14.1.1.5. Current & Future
Plans
14.1.2. Intas Pharmaceutical
Ltd.
14.1.3. Sunrise Remedies
Pvt. Ltd.
14.1.4. Cipla Limited
14.1.5. Zydus Cadila
Healthcare Ltd.
14.1.6. Nicholas Piramal
India Ltd.
14.1.7. Torrent Pharmaceuticals
Ltd.
14.1.8. Macleods
Pharmaceuticals Ltd.
14.1.9. Consern Pharma Pvt.
Ltd.
14.1.10.
Glenmark Lifesciences Ltd.
15.
Strategic Recommendations
16. About Us &
Disclaimer